Latest AI and machine learning research in other cancers for healthcare professionals.
Biomarker discovery for immunotherapy often requires reasoning across complex immune contexts. We pr...
The tumor microenvironment (TME) is a dynamic interplay among cancer, immune, and stromal cells that...
Identifying functional mutations that drive therapy resistance remains a major challenge in prostate...
While contemporary cancer treatment strategies have significantly prolonged the lives of patients, t...
Class I major histocompatibility complexes (MHCs), expressed on the surface of all nucleated cells, ...
Esophageal squamous cell carcinoma (ESCC) is a disease with limited tools for early screening and a ...
Resistance to targeted molecular therapies—both primary and acquired—remains a major obstacle to eff...
Effective lung cancer detection from CT scans remains critically challenged by class imbalance where...
This work introduces a modular, open-source computational pipeline for glioblastoma (GBM) vaccine de...
Bladder cancer exhibits sex-specific behavior, occurring more frequently in males but progressing to...
Synthetic enhancers with high specificity are crucial for therapeutic gene control. Although existin...
Diffuse midline glioma (DMG) is a near-universally lethal form of pediatric high-grade glioma, drive...
This work introduces a modular, open-source computational pipeline for glioblastoma (GBM) vaccine de...
Oral squamous cell carcinoma (OSCC) progression has been increasingly linked to dysbiosis of the ora...
The progression of lung adenocarcinoma (LUAD) from precancerous lesions to invasive carcinoma entail...
Rational discovery of function-specific protein modulators as well as activity-enhanced engineering ...
Accurate overall survival (OS) prediction is key for personalized treatment in breast cancer, but mu...
Early detection of hepatocellular carcinoma (HCC) is critical for improving patient outcomes, yet cu...
The BCL-XL anti-apoptotic protein is a clear cell Renal Cell Carcinoma (ccRCC) dependency; however, ...
Disseminated (DTCs) and circulating tumor cells (CTCs) are rare but pivotal in understanding cancer ...
Acute myeloid leukemia (AML) often enters remission after chemotherapy but frequently relapses due t...